Identifying Subgroup at High Risk of Transarterial Chemoembolization Failure Among Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation

Identifying Subgroup at High Risk of Transarterial Chemoembolization Failure Among Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation

Background/Objectives: Transarterial chemoembolization (TACE) is the most widely used bridging treatment for hepatocellular carcinoma (HCC) before liver transplantation (LT) but may be associated with dropout and post-LT HCC recurrence. We aimed to identify a subgroup of HCC LT candidates at high ri...

Full description

Saved in:
Bibliographic Details
Main Authors: Edoardo Poli, Marc-Antoine Allard, Astrid Laurent-Bellue, Maïté Lewin, Catherine Guettier, Daniel Azoulay, Audrey Coilly, Alexandre Dos Santos, Jamila Faivre, Eric Vibert, Alina Pascale, Clara Prud’homme, Antonio Sa Cunha, Faouzi Saliba, Jean Charles Duclos-Vallée, René Adam, Didier Samuel, Daniel Cherqui, Olivier Rosmorduc
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Livers
Subjects:
hepatocellular carcinoma
transarterial chemoembolization
liver transplantation
TACE failure
liver cancer
Online Access:https://www.mdpi.com/2673-4389/5/1/9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items